UBS Group’s Albireo Pharma, Inc. Common Stock ALBO Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q1
Sell
-6,164
Closed -$133K 9931
2022
Q4
$133K Buy
6,164
+5,399
+706% +$117K ﹤0.01% 4717
2022
Q3
$15K Buy
765
+359
+88% +$7.04K ﹤0.01% 6778
2022
Q2
$8K Sell
406
-40,892
-99% -$806K ﹤0.01% 7370
2022
Q1
$1.23M Buy
41,298
+25,796
+166% +$770K ﹤0.01% 3046
2021
Q4
$361K Buy
15,502
+14,882
+2,400% +$347K ﹤0.01% 4220
2021
Q3
$19K Buy
620
+20
+3% +$613 ﹤0.01% 6111
2021
Q2
$21K Sell
600
-27,401
-98% -$959K ﹤0.01% 6205
2021
Q1
$987K Buy
28,001
+27,911
+31,012% +$984K ﹤0.01% 3369
2020
Q4
$3K Sell
90
-5,214
-98% -$174K ﹤0.01% 7013
2020
Q3
$177K Buy
5,304
+1,032
+24% +$34.4K ﹤0.01% 4047
2020
Q2
$113K Sell
4,272
-3,093
-42% -$81.8K ﹤0.01% 4396
2020
Q1
$121K Sell
7,365
-9,042
-55% -$149K ﹤0.01% 4273
2019
Q4
$417K Buy
16,407
+6,445
+65% +$164K ﹤0.01% 4039
2019
Q3
$199K Buy
9,962
+7,093
+247% +$142K ﹤0.01% 4370
2019
Q2
$93K Buy
2,869
+2,844
+11,376% +$92.2K ﹤0.01% 4587
2019
Q1
$1K Sell
25
-3,329
-99% -$133K ﹤0.01% 6755
2018
Q4
$82K Sell
3,354
-11,151
-77% -$273K ﹤0.01% 4827
2018
Q3
$478K Buy
14,505
+3,287
+29% +$108K ﹤0.01% 3674
2018
Q2
$398K Buy
11,218
+2,077
+23% +$73.7K ﹤0.01% 3693
2018
Q1
$298K Hold
9,141
﹤0.01% 3751
2017
Q4
$234K Buy
+9,141
New +$234K ﹤0.01% 3916
2017
Q3
Sell
-1
Closed 6967
2017
Q2
$0 Sell
1
-244
-100% ﹤0.01% 6937
2017
Q1
$6K Buy
245
+244
+24,400% +$5.98K ﹤0.01% 6000
2016
Q4
$0 Sell
1
-929
-100% ﹤0.01% 6963
2016
Q3
$12K Buy
930
+918
+7,650% +$11.8K ﹤0.01% 5762
2016
Q2
$0 Sell
12
-559
-98% ﹤0.01% 6978
2016
Q1
$6K Buy
571
+174
+44% +$1.83K ﹤0.01% 6088
2015
Q4
$4K Buy
397
+385
+3,208% +$3.88K ﹤0.01% 6406
2015
Q3
$0 Sell
12
-416
-97% ﹤0.01% 7000
2015
Q2
$13K Buy
428
+350
+449% +$10.6K ﹤0.01% 5825
2015
Q1
$3K Sell
78
-54
-41% -$2.08K ﹤0.01% 6370
2014
Q4
$6K Buy
+132
New +$6K ﹤0.01% 6279